Ceftaroline Fosamil Acetate: Your Guide to CAS 866021-48-9 and Its Pharmaceutical Significance
In the realm of pharmaceutical manufacturing, precision and quality are paramount. Ceftaroline Fosamil Acetate Hydrate, identified by its unique CAS number 866021-48-9, represents a critical intermediate with significant implications for antibiotic development. This compound, typically supplied as a fine white powder, is the precursor to Ceftaroline, a potent antibiotic crucial for treating serious bacterial infections, particularly those caused by Gram-positive bacteria such as MRSA.
The chemical nature of Ceftaroline Fosamil Acetate Hydrate as a prodrug means it is administered in an inactive form and converted to the active Ceftaroline within the body. This formulation strategy enhances its pharmacological profile, allowing for effective treatment of acute bacterial skin and skin structure infections. Understanding its molecular formula, C24H27N8O11PS4, and molecular weight, approximately 762.75 g/mol, is essential for researchers and manufacturers involved in its synthesis and application.
For pharmaceutical companies looking to procure this vital intermediate, sourcing from reliable manufacturers, particularly in China, is a common and strategic choice. When you buy Ceftaroline Fosamil Acetate online, prioritize suppliers who offer verifiable quality through Certificates of Analysis (COA) and adhere to strict manufacturing protocols. This ensures that the material meets the high purity standards required for pharmaceutical use. The availability of this compound as a key ingredient empowers the development of next-generation antibiotics, vital in combating the growing threat of antibiotic resistance.
The journey from intermediate to finished pharmaceutical product is complex. Therefore, establishing a strong supply chain relationship with providers of Ceftaroline Fosamil Acetate is key. These partnerships not only ensure a consistent supply but also provide access to technical expertise and support necessary for successful drug development and manufacturing, ultimately contributing to improved global health outcomes.
The chemical nature of Ceftaroline Fosamil Acetate Hydrate as a prodrug means it is administered in an inactive form and converted to the active Ceftaroline within the body. This formulation strategy enhances its pharmacological profile, allowing for effective treatment of acute bacterial skin and skin structure infections. Understanding its molecular formula, C24H27N8O11PS4, and molecular weight, approximately 762.75 g/mol, is essential for researchers and manufacturers involved in its synthesis and application.
For pharmaceutical companies looking to procure this vital intermediate, sourcing from reliable manufacturers, particularly in China, is a common and strategic choice. When you buy Ceftaroline Fosamil Acetate online, prioritize suppliers who offer verifiable quality through Certificates of Analysis (COA) and adhere to strict manufacturing protocols. This ensures that the material meets the high purity standards required for pharmaceutical use. The availability of this compound as a key ingredient empowers the development of next-generation antibiotics, vital in combating the growing threat of antibiotic resistance.
The journey from intermediate to finished pharmaceutical product is complex. Therefore, establishing a strong supply chain relationship with providers of Ceftaroline Fosamil Acetate is key. These partnerships not only ensure a consistent supply but also provide access to technical expertise and support necessary for successful drug development and manufacturing, ultimately contributing to improved global health outcomes.
Perspectives & Insights
Agile Reader One
“The availability of this compound as a key ingredient empowers the development of next-generation antibiotics, vital in combating the growing threat of antibiotic resistance.”
Logic Vision Labs
“Therefore, establishing a strong supply chain relationship with providers of Ceftaroline Fosamil Acetate is key.”
Molecule Origin 88
“These partnerships not only ensure a consistent supply but also provide access to technical expertise and support necessary for successful drug development and manufacturing, ultimately contributing to improved global health outcomes.”